MediciNova
MNOV
53 hedge funds and large institutions have $52.8M invested in MediciNova in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 6 closing their positions.
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
6% more funds holding
Funds holding: 50 → 53 (+3)
1.1% more ownership
Funds ownership: 21.61% → 22.71% (+1.1%)
2% more capital invested
Capital invested by funds: $51.6M → $52.8M (+$1.17M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
37% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 19
85% less call options, than puts
Call options by funds: $82K | Put options by funds: $556K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JSMC
Jess S. Morgan & Co
Los Angeles,
California
|
+$2.03M |
| 2 |
GC
Greenlight Capital
New York
|
+$1.07M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$345K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$191K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$190K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$323K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$162K |
| 3 |
State Street
Boston,
Massachusetts
|
-$148K |
| 4 |
SG Americas Securities
New York
|
-$125K |
| 5 |
BlackRock
New York
|
-$124K |
MNOV Hedge Fund Activity: Q3 2020 in Review
53 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q3 2020, worth a combined $52.8M — up 2.3% from $51.6M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new MNOV positions and 6 closed out — a net gain of 3 holders — while 12 added to existing stakes and 19 trimmed.
The largest buyer was Jess S. Morgan & Co, opening a new position worth an estimated $2.03M. The largest seller was D.E. Shaw & Co, cutting an estimated $323K.
- 53 institutional investors held MediciNova (MNOV) as of Q3 2020, up from 50 in Q2 2020.
- Funds reported $52.8M of MediciNova stock for Q3 2020, up 2.3% quarter-over-quarter.
- 9 funds opened new MediciNova positions in Q3 2020 and 6 closed out, a net change of +3 holders.
- The largest MediciNova buyer in Q3 2020 was Jess S. Morgan & Co, an estimated $2.03M added.
- The largest MediciNova seller in Q3 2020 was D.E. Shaw & Co, an estimated $323K sold.
Based on aggregated 13F filings for Q3 2020.